Nucleic acid-linked conjugates and methods for making and using them
View Patent ↗Compounds that are readily dissociable conjugates of a multiplicity of biologically active molecules are formed by bonding to each biologically active molecule one or more oligonucleotide chains selected to comprise partially complementary sequences that form duplexes with other such oligonucleotides attached to other biologically active molecules. The claimed conjugates and methods for preparing the conjugates of the invention can be used to link two or more biologically active molecules, as well as conjugating a multiplicity of biologically active molecules. In alternative embodiments, conjugates comprising such covalently linked oligonucleotides linked by one or a multiplicity of “bridging” oligonucleotides are provided. Methods for making these different types of conjugates and for using such conjugates for research, immunoassay, medical and technical applications are also provided by the invention. The disclosed methods provide for the formation of intermolecular links which are hydrophilic, of relatively low toxicity and antigenicity, are as flexible and extensible as desired, and are stable yet dissociable. Both the components and the conjugates of the invention can be isolated and purified with relative ease compared with other intermediates and conjugates.
1. A conjugate molecule comprising a multiplicity of proteins, wherein at least a first and second proteins are linked to each other by a flexible nucleic acid linker that is flexible due to the flexibility of single stranded nucleic acid such that the first and second proteins can bind to nonoverlapping epitopes on a desirable analyte and wherein the linker is formed by two nucleic acid single chains of which the first is covalently linked to the first protein and the second is covalently linked to the second protein, and wherein the nucleic acid single chains form a double-stranded heteroduplex of from 10 to 30 base-pairs in length, and wherein at least one of the first and second single stranded nucleic acids has a segment comprising from 6 to 20 consecutive nucleotides that remain free of any base-pairing interaction, and connects the covalent link to the corresponding protein to the heteroduplex.
2. The conjugate molecule of claim 1 , wherein first and second nucleic acid single chains are covalently linked to corresponding proteins both by the 3′ end or both by the 5′ end, or one by the 3′ end and one by the 5′ end.
3. The conjugate molecule of claim 1 , wherein the first and second proteins are the same or different.
4. A conjugate molecule comprising a multiplicity of proteins wherein at least a first and a second protein are linked to each other by a flexible nucleic acid linker that is flexible due to the flexibility of single-stranded nucleic acid such that the first and second proteins can bind to nonoverlapping epitopes on a desirable analyte and wherein the linker is formed of two nucleic acid single chains of which the first is covalently linked to the first protein and the second is covalently linked to the second protein, and wherein the first and second nucleic acid single chains each form double-stranded heteroduplexes of from 10 to 30 base pairs in length with a third nucleic acid and wherein at least one of the first or second nucleic acid single chains has a segment comprised of from 6 to 20 consecutive nucleotides that remain free from any base-pairing interaction and connects the covalent link to the corresponding protein to the segment of the same nucleic acid single chain that forms a heteroduplex with the third nucleic acid, and wherein the third nucleic acid may be a nucleic acid single chain or a concatenate of nucleic acid chains and wherein the third nucleic acid is not covalently bound to either the first or the second protein.
5. The conjugate molecule of claim 4 , wherein the first and second nucleic acid single chains are covalently linked to corresponding proteins both by the 3′ end or both by the 5′ end, or one by the 3′ end and one by the 5′ end.
6. The conjugate molecule of claim 4 , wherein the first and second proteins are the same or different.